These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 25861726)

  • 1. Olefins and chemical regulation in Europe: REACH.
    Penman M; Banton M; Erler S; Moore N; Semmler K
    Chem Biol Interact; 2015 Nov; 241():59-65. PubMed ID: 25861726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of REACH-derived no-effect levels for workers with EU indicative occupational exposure limit values and national limit values in Finland.
    Tynkkynen S; Santonen T; Stockmann-Juvala H
    Ann Occup Hyg; 2015 May; 59(4):401-15. PubMed ID: 25638729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The European Union's REACH regulation: a review of its history and requirements.
    Williams ES; Panko J; Paustenbach DJ
    Crit Rev Toxicol; 2009; 39(7):553-75. PubMed ID: 19650717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A scoping survey of attitudes towards occupational exposure limits and REACH derived no effect levels for workers among chemical risk managers at Swedish workplaces.
    Schenk L
    Int J Occup Med Environ Health; 2020 Sep; 33(5):611-620. PubMed ID: 32699425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generic exposure scenarios: their development, application, and interpretation under REACH.
    Money C; Margary A; Noij D; Hommes K
    Ann Occup Hyg; 2011 Jun; 55(5):451-64. PubMed ID: 21551289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated testing and intelligent assessment-new challenges under REACH.
    Ahlers J; Stock F; Werschkun B
    Environ Sci Pollut Res Int; 2008 Oct; 15(7):565-72. PubMed ID: 18818964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derived no-effect levels (DNELs) under the European chemicals regulation REACH--an analysis of long-term inhalation worker-DNELs presented by industry.
    Schenk L; Deng U; Johanson G
    Ann Occup Hyg; 2015 May; 59(4):416-38. PubMed ID: 25471229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental Risk Assessment of Technical Mixtures Under the European Registration, Evaluation, Authorisation and Restriction of Chemicals-A Regulatory Perspective.
    Galert W; Hassold E
    Integr Environ Assess Manag; 2021 May; 17(3):498-506. PubMed ID: 33448633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpreting REACH guidance in the determination of the derived no effect level (DNEL).
    Kreider ML; Spencer Williams E
    Regul Toxicol Pharmacol; 2010 Nov; 58(2):323-9. PubMed ID: 20655351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Butadiene--progress under the European Union Existing Substances Regulation.
    Fraser I
    Chem Biol Interact; 2001 Jun; 135-136():103-7. PubMed ID: 11397384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure scenarios for workers.
    Marquart H; Northage C; Money C
    J Expo Sci Environ Epidemiol; 2007 Dec; 17 Suppl 1():S16-25. PubMed ID: 17851448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trade Union Priority List for REACH authorisation.
    Romano D; Santos T; Gadea R
    J Epidemiol Community Health; 2011 Jan; 65(1):8-13. PubMed ID: 20508006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Safe usage of chemicals in European Union countries].
    Graczyk A; Czerczak S; Barański B
    Med Pr; 2010; 61(3):333-40. PubMed ID: 20677433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. REACH: next step to a sound chemicals management.
    Van der Wielen A
    J Expo Sci Environ Epidemiol; 2007 Dec; 17 Suppl 1():S2-6. PubMed ID: 17637708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of REACH on classification for human health hazards.
    Oltmanns J; Bunke D; Jenseit W; Heidorn C
    Regul Toxicol Pharmacol; 2014 Nov; 70(2):474-81. PubMed ID: 25128672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicological comments to the discussion about REACH.
    Greim H; Arand M; Autrup H; Bolt HM; Bridges J; Dybing E; Glomot R; Foa V; Schulte-Hermann R
    Arch Toxicol; 2006 Mar; 80(3):121-4. PubMed ID: 16411136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transparency of chemical risk assessment data under REACH.
    Ingre-Khans E; Ågerstrand M; Beronius A; Rudén C
    Environ Sci Process Impacts; 2016 Dec; 18(12):1508-1518. PubMed ID: 27819710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Background of REACH in EU regulations on evaluation of chemicals.
    Foth H; Hayes A
    Hum Exp Toxicol; 2008 Jun; 27(6):443-61. PubMed ID: 18784197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the potential human health risks from exposure to complex substances in accordance with REACH requirements. "White spirit" as a case study.
    McKee RH; Tibaldi R; Adenuga MD; Carrillo JC; Margary A
    Regul Toxicol Pharmacol; 2018 Feb; 92():439-457. PubMed ID: 29069582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A quantitative comparison of the safety margins in the european indicative occupational exposure limits and the derived no-effect levels for workers under REACH.
    Schenk L; Johanson G
    Toxicol Sci; 2011 Jun; 121(2):408-16. PubMed ID: 21389111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.